TransCode Therapeutics Inc (RNAZ) Stock Price

8.98 ▼ -0.32 (-3.44%)
Open: 10.00 Vol: 7.32K Day's range: 8.93 - 10.00 Feb 03, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
RNAZ Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 9.43▼ 9.60▼ 9.52▼ 9.87▼ 9.06▼
MA10 9.58▼ 9.69▼ 10.09▼ 10.19▼ 8.57▲
MA20 9.95▼ 10.45▼ 10.90▼ 9.24▼ 9.85▼
MA50 10.50▼ 10.19▼ 9.33▼ 8.68▲ 12.12▼
MA100 9.29▼ 9.22▲ 9.18▲ 10.07▼ 34.45▼
MA200 9.58▼ 10.96▼ 10.81▼ 9.75▼ 6,764.58▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.082▼ -0.172▼ -0.311▼ -0.031▼ 1.229▲
RSI 37.246▼ 38.148▼ 41.690▼ 47.959▼ 42.938▼
STOCH 27.771     25.998     15.426▼ 39.863     47.833    
WILL %R -97.800▼ -97.980▼ -98.937▼ -76.533▼ -55.546    
CCI -122.355▼ -86.747     -113.505▼ -38.911     41.729    
Latest Filters Detected On RNAZ
RSI $RNAZ RSI(14) Crossed Below 50 Set Alert
▼ MACD $RNAZ MACD(12,26,9) Crossed Below Signal Line Set Alert
▲ GAP $RNAZ Open Gap Up %5 Set Alert
▲ GAP $RNAZ Open Gap Up %3 Set Alert
▲ GAP $RNAZ Open Gap Up %2 Set Alert
CDL $RNAZ Marubozu Candlestick Pattern Detected Set Alert
TransCode Therapeutics Inc News
TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode's Phase 1 trial
Thursday, December 11, 2025 05:05 AM
BOSTON, Dec. 11, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) and Quantum Leap Healthcare Collaborative ("Quantum Leap") today announce a new collaboration to evaluate TransCode's ...
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique ...
Wednesday, October 08, 2025 06:01 AM
TransCode acquires 100% of the issued and outstanding interests of Polynoma from CK Life Sciences Concurrent equity investment of $25 Million from CK Life Sciences into TransCode TransCode expands its ...
TransCode Acquires Polynoma From CK Life Sciences
Wednesday, October 08, 2025 05:24 AM
(RTTNews) - TransCode Therapeutics (RNAZ) has entered into a definitive agreement to acquire Polynoma, a privately-held biotechnology immuno-oncology company. Polynoma is developing a late-stage ...
RNAZ historical stock data
date open high low close volume
03/02/26 10.00 10.00 8.93 8.98 7,322
02/02/26 9.50 9.96 9.2066 9.30 6,734
30/01/26 10.90 10.90 9.265 9.49 16,660
29/01/26 10.67 10.80 9.90 10.4775 14,129
28/01/26 11.365 11.365 10.395 11.085 27,290
27/01/26 12.14 12.34 11.62 11.67 21,891
26/01/26 10.19 12.60 10.17 12.34 75,930
23/01/26 9.57 10.50 9.34 9.87 20,615
22/01/26 9.40 9.73 9.05 9.32 11,670
21/01/26 8.81 9.40 8.66 9.38 9,751
Quote Details
52wk Low:6.083
52wk High:357.56
Vol:7.32K
Avg Vol(3m):1.1M
1Y Chng:-96.58%
1M Chng:+13.38%
Add to Watch List
More Information
Index US Composite
Market Cap. 8.53M